Learn More
Medchemexpress LLC Linaprazan | 248919-64-4 | MFCD30343852 | 98.8% | 366.46 g/mol | C21H26N4O2 | 25 MG

Supplier: Medchemexpress LLC HY10041225MG
Linaprazan is a potassium-competitive H+,K+-ATPase inhibitor supplied for research and analytical applications. It exhibits K+-competitive inhibition of the gastric proton pump (reported IC50 ≈ 1.0 ± 0.2 μM) and has demonstrated oral activity in preclinical studies of acid-related disorders. This material is for research use only and not intended for human use.
- Potassium-competitive H+,K+-ATPase inhibition (IC50 ≈ 1.0 μM).
- Orally active in preclinical models of reflux and acid suppression.
- Available as solid and DMSO solution formats.
- High purity suitable for analytical and research applications.
- Multiple package sizes available, including 25 mg.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.